NPPA and autoimmune disease: Since pharmacological modulation of KP activity can affect the immune response and inhibit processes involved in the progression of numerous diseases, it seems to be a promising solution for treating various disorders accompanied by pathologically severe inflammation, including autoimmune diseases [11,15,49].